跳至主要内容
临床试验/NCT02416375
NCT02416375已完成不适用

A Standardized Multi-centre Analysis of Remote Monitoring in Cystic Fibrosis Adult Patients to Reduce Pulmonary Exacerbations

Papworth Hospital NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
147
试验地点
1
主要终点
Home monitoring possible in adult Cystic Fibrosis patients

研究概览

简要总结

The study aims to establish if it is possible for people with Cystic Fibrosis to monitor a number of parameters on a daily basis at home which might predict respiratory infections before they have symptoms and which might also predict treatment failures before this is obvious with conventional measures.

详细描述

Participants will collect the following clinical information daily: pulse rate and oxygen saturations, wellness and cough scores, spirometry measurements, physical activity, temperature, weight and sleep quantity and quality. The patients will also collect daily sputum samples.

Data will be collected via Bluetooth-enabled devices and transmitted via a Smart-phone to a secure National Health Service approved web-based site to be analyzed.

The information obtained will allow the investigators to develop a software program that will identify signals that can predict the onset of a chest infection before symptoms develop.

The investigators will also measure specific substances in sputum to identify changes before, during and after chest infections. The investigators hope this additional information will enable them to more accurately predict the onset of chest infections in cystic fibrosis.

The results of this study will determine if it is possible to develop a simple sputum test for patients to use at home in combination with other home-based assessments of well-being to provide an early warning system of a chest infection before patients feel unwell.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride.
  • Age ≥ 18 years of age.
  • A history of at least 1 acute pulmonary exacerbation in the past 12 months.
  • Able to provide written informed consent.
  • Willing and able to produce daily sputum samples.
  • Willing and able to provide daily telemetric measure of several physiological parameters.

排除标准

  • Patients unable to provide written informed consent
  • Patients unable to produce daily sputum samples
  • Less than 1 infective pulmonary exacerbation in 12 months
  • Lung transplant recipients

结局指标

主要结局

Home monitoring possible in adult Cystic Fibrosis patients

时间窗: 6 months

This will be measured by the number of patients recruited into the study and the patients compliance / adherence to the study protocol

次要结局

  • Whether daily monitoring can provide early warning of a new chest infection(6 months)
  • Development of a web-based machine learning tool(6 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Judy Ryan

Research & Database Manager

Papworth Hospital NHS Foundation Trust

研究点 (1)

Loading locations...

相似试验